ONEMEDNET CORPORATION Interest Expense Nonoperating
ONEMEDNET CORPORATION (ONMD) reported Interest Expense Nonoperating of $9.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- ONEMEDNET CORPORATION interest expense nonoperating for the quarter ending 2026-06-30 was $9.00K, a 59.09% decline year-over-year.
- ONEMEDNET CORPORATION interest expense nonoperating for the quarter ending 2026-03-31 was $10.00K, a 67.74% decline year-over-year.
- ONEMEDNET CORPORATION interest expense nonoperating for the quarter ending 2025-12-31 was $8.00K, a 70.37% decline year-over-year.
- ONEMEDNET CORPORATION interest expense nonoperating for the quarter ending 2025-09-30 was $6.00K, a 83.33% decline year-over-year.
- ONEMEDNET CORPORATION interest expense nonoperating for fiscal 2023 was $11.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.00K 10-Q · filed 2026-08-14 | $19.00K 10-Q · filed 2026-08-14 | $27.00K derived: sum of 3 quarters · filed 2026-08-14 | $33.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $10.00K S-1/A · filed 2026-07-08 | $18.00K derived: sum of 2 quarters · filed 2026-07-08 | $24.00K derived: sum of 3 quarters · filed 2026-07-08 | $46.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $8.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $14.00K derived: sum of 2 quarters · filed 2026-07-08 | $36.00K derived: sum of 3 quarters · filed 2026-08-14 | $67.00K S-1/A · filed 2026-07-08 |
| 2025-09-30 | $6.00K 10-Q · filed 2025-11-14 | $28.00K derived: sum of 2 quarters · filed 2026-08-14 | $59.00K 10-Q · filed 2025-11-14 | $86.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $22.00K 10-Q · filed 2026-08-14 | $52.00K 10-Q · filed 2026-08-14 | $80.00K derived: sum of 3 quarters · filed 2026-08-14 | $116.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $31.00K S-1/A · filed 2026-07-08 | $58.00K derived: sum of 2 quarters · filed 2026-07-08 | $94.00K derived: sum of 3 quarters · filed 2026-07-08 | $135.00K derived: sum of 4 quarters · filed 2026-07-08 |
| 2024-12-31 | $27.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $63.00K derived: sum of 2 quarters · filed 2026-07-08 | $104.00K derived: sum of 3 quarters · filed 2026-07-08 | $147.00K S-1/A · filed 2026-07-08 |
| 2024-09-30 | $36.00K 10-Q · filed 2025-11-14 | $77.00K derived: sum of 2 quarters · filed 2025-11-14 | $120.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $41.00K 10-Q · filed 2025-08-13 | $83.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $42.00K 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $11.00K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |